Inhibition of FASN in CAFs or blocking the uptake of fatty acids by CRC cells, either through siRNA-mediated knockdown or by using sulfo-N-succinimidyloleate sodium and CD36 monoclonal antibody, successfully reduced CRC cell migration in vitro and in vivo. The gene discussed is FASN; the disease is colorectal carcinoma.